Literature DB >> 9539709

Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans.

A J Rhomberg1, S Ernst, R Sasisekharan, K Biemann.   

Abstract

Difficulties in determining composition and sequence of glycosaminoglycans, such as those related to heparin, have limited the investigation of these biologically important molecules. Here, we report methodology, based on matrix-assisted laser desorption ionization MS and capillary electrophoresis, to follow the time course of the enzymatic degradation of heparin-like glycosaminoglycans through the intermediate stages to the end products. MS allows the determination of the molecular weights of the sulfated carbohydrate intermediates and their approximate relative abundances at different time points of the experiment. Capillary electrophoresis subsequently is used to follow more accurately the abundance of the components and also to measure sulfated disaccharides for which MS is not well applicable. For those substrates that produce identical or isomeric intermediates, the reducing end of the carbohydrate chain was converted to the semicarbazone. This conversion increases the molecular weight of all products retaining the reducing terminus by the "mass tag" (in this case 56 Da) and thus distinguishes them from other products. A few picomoles of heparin-derived, sulfated hexa- to decasaccharides of known structure were subjected to heparinase I digestion and analyzed. The results indicate that the enzyme acts primarily exolytically and in a processive mode. The methodology described should be equally useful for other enzymes, including those modified by site-directed mutagenesis, and may lead to the development of an approach to the sequencing of complex glycosaminoglycans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539709      PMCID: PMC22461          DOI: 10.1073/pnas.95.8.4176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

2.  One- and two-dimensional 13C-n.m.r. characterization of two series of oligosaccharides derived from porcine intestinal mucosal heparin by degradation with heparinase.

Authors:  P Gettins; A P Horne
Journal:  Carbohydr Res       Date:  1992-01       Impact factor: 2.104

Review 3.  Structure and biological activity of heparin.

Authors:  B Casu
Journal:  Adv Carbohydr Chem Biochem       Date:  1985       Impact factor: 12.200

4.  Heparinase I from Flavobacterium heparinum. Role of positive charge in enzymatic activity.

Authors:  R Godavarti; R Sasisekharan
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

5.  Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases.

Authors:  K G Rice; R J Linhardt
Journal:  Carbohydr Res       Date:  1989-07-15       Impact factor: 2.104

6.  Capillary electrophoresis for the analysis of chondroitin sulfate- and dermatan sulfate-derived disaccharides.

Authors:  A al-Hakim; R J Linhardt
Journal:  Anal Biochem       Date:  1991-05-15       Impact factor: 3.365

Review 7.  Heparan sulfate: a piece of information.

Authors:  M Salmivirta; K Lidholt; U Lindahl
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

8.  The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.

Authors:  B Casu; P Oreste; G Torri; G Zoppetti; J Choay; J C Lormeau; M Petitou; P Sinäy
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

9.  Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor.

Authors:  D J Tyrrell; M Ishihara; N Rao; A Horne; M C Kiefer; G B Stauber; L H Lam; R J Stack
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  23 in total

1.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Four decades of structure determination by mass spectrometry: from alkaloids to heparin.

Authors:  Klaus Biemann
Journal:  J Am Soc Mass Spectrom       Date:  2002-11       Impact factor: 3.109

3.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

Authors:  S Ernst; A J Rhomberg; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Vascular scaffolds with enhanced antioxidant activity inhibit graft calcification.

Authors:  Bin Jiang; Rachel Suen; Jiao-Jing Wang; Zheng J Zhang; Jason A Wertheim; Guillermo A Ameer
Journal:  Biomaterials       Date:  2017-08-14       Impact factor: 12.479

5.  Sequence analysis of heparan sulphate and heparin oligosaccharides.

Authors:  R R Vivès; D A Pye; M Salmivirta; J J Hopwood; U Lindahl; J T Gallagher
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

6.  Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.

Authors:  Z Shriver; M Sundaram; G Venkataraman; J Fareed; R Linhardt; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Biochemical characterization of the chondroitinase ABC I active site.

Authors:  Vikas Prabhakar; Rahul Raman; Ishan Capila; Carlos J Bosques; Kevin Pojasek; Ram Sasisekharan
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 8.  On-line separations combined with MS for analysis of glycosaminoglycans.

Authors:  Joseph Zaia
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

Review 9.  The structural elucidation of glycosaminoglycans.

Authors:  Vikas Prabhakar; Ishan Capila; Ram Sasisekharan
Journal:  Methods Mol Biol       Date:  2009

10.  Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.

Authors:  A J Rhomberg; Z Shriver; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.